Cancer care in Aveyron advanced on Sunday as the Rodez hospital center established a partnership with Toulouse’s Oncopole Claudius-Regaud to expand local oncology services, actu.fr reported, according to Actu.
The collaboration introduces an oncogenetics consultation affiliated with the Oncopole at the Rodez hospital, allowing patients to receive care locally while relying on the expertise of the regional oncogenetics team.
“Elle permet aux patients de bénéficier d’une prise en charge de proximité tout en s’appuyant sur l’expertise de l’équipe régionale d’oncogénétique,” the Rodez hospital center said in a statement welcoming the arrangement.
The partnership also links the Rodez center with the Oncopole laboratory for three specialized examinations. The first, BRCA1/BRCA2, involves a search for genetic mutations that can help steer certain therapeutic strategies toward targeted treatments.
The second, MSK-ACCESS®, is a molecular analysis by liquid biopsy performed from a blood draw, designed to detect specific genetic anomalies associated with cancers. The third, PROSIGNA® (PAM50), analyzes the expression of 50 genes in certain breast cancers to better characterize the tumor and assess the risk of recurrence.
“Ce partenariat illustre la volonté des deux établissements de renforcer leur coopération pour proposer aux patients aveyronnais un accès facilité à des examens spécialisés et à une expertise complémentaire, tout en favorisant une prise en charge adaptée à leurs besoins,” the hospital management said.
The Rodez oncology department manages all adult cancers except specific treatments such as therapeutic intensification and certain blood diseases. Its inpatient sector has 12 individual rooms, the chemotherapy sector offers 21 places (12 beds and 9 chairs), and the day hospital sector provides 19 places (beds and chairs) dedicated to the facility’s various medical specialties.
The Rodez hospital center’s oncology department manages all adult cancers except therapeutic intensification and certain blood diseases, a scope confirmed on its own pages. Its inpatient sector comprises 12 individual rooms, while the chemotherapy sector in the Médecine Ambulatoire unit provides 21 places (12 beds and 9 chairs) open Monday to Friday, 8 am to 8 pm, and the day-hospital sector adds 19 places for the facility’s various medical specialties.
The announcement coincides with Octobre Rose, a series of events dedicated to the fight against breast cancer. The Mammobile, a mobile screening unit, visited four Aveyron communes in November 2026: Naucelle and Réquista on November 2 and 3, Camarès on November 4, and Saint-Sernin-sur-Rance on November 5.
Worth a look